Arkema S.A.
ARKAF
$90.09
$9.4411.71%
Weiss Ratings | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | C+ | |||
Rating Factors | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Weak | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.10 | |||
Price History | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 11.70% | |||
30-Day Total Return | 15.31% | |||
60-Day Total Return | 1.91% | |||
90-Day Total Return | 1.91% | |||
Year to Date Total Return | 23.36% | |||
1-Year Total Return | -14.77% | |||
2-Year Total Return | -8.63% | |||
3-Year Total Return | -34.95% | |||
5-Year Total Return | 47.09% | |||
52-Week High % Change | -24.63% | |||
52-Week Low % Change | 11.06% | |||
Price | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $107.00 | |||
52-Week Low Price | $72.62 | |||
52-Week Low Price (Date) | Jan 10, 2025 | |||
52-Week High Price (Date) | Mar 28, 2024 | |||
Valuation | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 6.90B | |||
Enterprise Value | 9.89B | |||
Price/Earnings (TTM) | 17.93 | |||
Earnings Per Share (TTM) | 4.50 | |||
Earnings Per Share Growth | -16.91% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.62 | |||
Price/Book (Q) | 0.87 | |||
Enterprise Value/Revenue (TTM) | 0.86 | |||
Price | $90.09 | |||
Enterprise Value/EBITDA (TTM) | 6.04 | |||
Enterprise Value/EBIT | 12.15 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 80.00M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 77.65% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 33 1 49 00 80 80 | |||
Address | -- | |||
Website | www.arkema.com | |||
Country | France | |||
Year Founded | 2003 | |||
Profitability | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 7.07% | |||
Profit Margin | 3.72% | |||
Management Effectiveness | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 2.87% | |||
Return on Equity | 4.76% | |||
Income Statement | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 10.33B | |||
Total Revenue (TTM) | 10.33B | |||
Revenue Per Share | $129.07 | |||
Gross Profit (TTM) | 2.10B | |||
EBITDA (TTM) | 1.47B | |||
EBIT (TTM) | 730.74M | |||
Net Income (TTM) | 384.35M | |||
Net Income Avl. to Common (TTM) | 384.35M | |||
Total Revenue Growth (Q YOY) | 1.29% | |||
Earnings Growth (Q YOY) | -65.56% | |||
EPS Diluted (TTM) | 4.50 | |||
EPS Diluted Growth (Q YOY) | -192.37% | |||
Balance Sheet | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.08B | |||
Cash Per Share (Q) | $26.05 | |||
Total Current Assets (Q) | 5.17B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 8.03B | |||
Current Ratio (Q) | 2.009 | |||
Book Value Per Share (Q) | $93.23 | |||
Total Assets (Q) | 15.75B | |||
Total Current Liabilities (Q) | 2.57B | |||
Total Debt (Q) | 4.71B | |||
Total Liabilities (Q) | 7.71B | |||
Total Common Equity (Q) | 7.79B | |||
Cash Flow | ARKAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -1.01B | |||
Cash from Financing (TTM) | -226.79M | |||
Net Change in Cash (TTM) | -34.40M | |||
Levered Free Cash Flow (TTM) | 355.80M | |||
Cash from Operations (TTM) | 1.21B | |||